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Among the 55 million people in Europe diagnosed as having 
diabetes mellitus (www.diabetesatlas.org), the lifetime risk 
of developing a foot complication—often infected wounds—
could be as high as 25% (Boulton et al. 2005). Many of the 
patients with severe infections will require amputation within 
the foot or above the ankle. Approximately 85% of lower-
limb amputations in patients with diabetes are preceded by 
infected foot ulceration (Adler et al. 1999).
Polymicrobial  infections  predominate  in  severe  diabetic 
foot infections (Dowd et al. 2008a) and the medical commu-
nity is now beginning to realize that the diversity of bacterial 
populations in chronic wounds (Dowd et al. 2008b, James et 
al. 2008) may be an important contributor to the chronicity 
of wounds, such as diabetic foot ulcers. In addition, another 
obstacle to the healing of chronic wounds is the biofilm mode 
of growth of the infecting organisms (Wolcott and Rhoads 
2008). By definition, biofilms are microbial populations that 
are attached to a surface, or to the surfaces of other organ-
isms, and encase themselves in hydrated extracellular poly-
meric substance (EPS), which is also referred to as “slime”. 
The chemical and physical properties of EPS can vary, but it 
is mainly composed of polysaccharides. EPS is also associ-
ated with other macromolecules such as proteins, DNA, lipids, 
and even humic substances (Nielsen et al. 1996, Tsuneda et 
al. 2003).
Biofilm-related  diseases  are  usually  persistent  infections 
that develop slowly. They appear to be rarely cleared by the 
host immune system and are highly resistant to antimicrobial 
therapy (Stewart and Costerton 2001). For example, antibi-
otic resistance in biofilm bacteria of up to 1,000 times that 
of planktonic bacteria has been extensively documented in 
experiments in vitro (Stewart and Costerton 2001). Infected 
diabetic foot ulcers share these characteristics, and it has been 
hypothesized that biofilms may play a role in these infections 
(Davis et al. 2006, Dowd et al. 2008a). We evaluated debrided 
soft tissue from infected diabetic foot ulcers by confocal laser 
scanning  microscopy  (CLSM).  Part  of  the  debrided  tissue 
was also analyzed using culture methods to evaluate bacterial 
diversity of the biofilms.
Case 1
A 58-year-old man with type-2 diabetes since 2000 presented 
with a non-healing ulcer on the top of the left great toe. He 
was initially treated with multiple courses of antibiotics and 
a total contact cast followed by a rigid orthopedic shoe and 
multiple debridements at the outdoor clinic. After 7 months, 
we decided to perform an amputation of the toe because of 
the non-healing tendency of the ulcer. His HbA1c at that time 
was 7.2.
Case 2
A  69-year-old  man  with  type-1  diabetes  presented  at  the 
orthopedic outdoor patient clinic with a non-healing ulcer on 
the medial, plantair site of the left foot at the level of the os 
naviculare. He was treated with oral antibiotics (ciprofloxacin 
2 × 500 mg and clindamycin 3 × 600 mg) for 6 weeks and 
a total contact cast and multiple debridements at the outpa-
tient clinic. After 6 months, we decided to perform a clinical 
debridement in the operating theater due to insufficient heal-
ing of the ulcer. 
Soft tissue samples were collected with sterile tools from 
these 2 patients when undergoing deep debridement in the 
operating theater. Once the debridement was complete, mate-
rial debrided from the wound was prepared for CLSM exami-
nation and microbiological culture. Both patients gave their 
oral consent. 
Tissue  samples  were  stained  with  LIVE/DEAD  Baclight 
viability  stain  (Molecular  Probes  Europe  BV,  Leiden,  the 
Netherlands) containing SYTO 9 dye (fluorescent green) and 
propidium iodide (fluorescent red) to differentiate between 
living and dead bacteria, respectively. In addition, samples 
were stained with calcofluor white (0.1 mM; fluorescent blue), 
a polysaccharide-binding dye used to visualize EPS. Samples 
were examined using a Leica TCS-SP2 CSLM microscope 
(Leica  Microsystems  Heidelberg  GmbH,  Heidelberg,  Ger-
many). 
Results and Discussion
The clinical progression of both patients corresponded to the 
behavior expected when there is a chronic underlying biofilm 
infection that is resistant to standard antibiotic therapy. CLSM 
examination revealed the presence of densely aggregated col-384  Acta Orthopaedica 2011; 82 (3): 383–385
onies of bacteria often surrounded by EPS and host-cell debris 
(Figures 1 and 2). The distribution was patchy, the presence of 
bacteria ranging from single cells to large aggregates of grape-
like clusters (Figure 1A and Figure 2A). The bacteria in these 
clusters  were  viable  as  they  turned  fluorescent  green  after 
staining with LIVE/DEAD Baclight viability stain. Calcofluor 
white stained the EPS excreted by the bacteria fluorescent 
blue (Figure 1B and Figure 2B). These morphological obser-
vations are characteristic of biofilms and they provide evi-
dence that biofilms can be present in chronic infected diabetic 
and these findings were confirmed by culture on agar plates. In 
both cases, S. aureus (MRSA-negative) was retrieved from the 
ulcer, while other bacteria were also present in each ulcer. To 
our knowledge, this is the first reported direct demonstration 
of bacterial infections associated with a diabetic foot ulcer 
that fulfill all of the established criteria for a biofilm infection 
(Hall-Stoodley et al. 2006, Stoodley et al. 2008). 
Frequently, ulceration in the diabetic foot is partly caused 
by vascular insufficiency; because of the poor blood flow, anti-
biotics cannot easily get to the site of the infection. Plans for 
Figure 1. CLSM images of biofilm on soft tissue from patient 1. Overlay projection (includes all the 
slices in an image stack) of the biofilm at the center of the ulcer base (A) and at the edge of the ulcer 
base (B). Bar represents 75 µm. CLSM examination revealed the presence of bacteria ranging from 
single cells to large aggregates of grape-like clusters (panel A). The bacteria in these clusters were 
viable, as they appeared fluorescent green after LIVE/DEAD Baclight viability stain. Calcofluor white 
(blue) stained the EPS excreted by the bacteria (panel B). Host nuclei and fibrous material stained 
red with propidium iodide (panels A and B).
Figure 2. CLSM images of biofilm on soft tissue from patient 2. Overlay projection of the biofilm (A) 
and a projected side-view (B), meaning the biofilm is visualized from the top and from the side (XZ-
plane and YZ-plane, respectively). Bar represents 75 µm. CLSM examination showed that the biofilm 
distribution was patchy (panel A), with some sites containing large clusters of bacteria and other 
regions showing hardly any evidence of infection. The bacteria were frequently embedded within a 
self-produced matrix of EPS (panel B). In addition, the infected ulcer was quite superficial, as can be 
concluded from the biofilm thickness shown in panel B.
foot ulcers. In addition, the infected 
ulcer was quite superficial—as can 
be concluded from the thickness of 
the biofilm shown in Figure 2B.
Standard microbiological culture 
revealed a biofilm species composi-
tion in patient 1 of Staphylococcus 
aureus  (MRSA-negative),  Proteus 
vulgaris, Enterococcus avium, and 
Enterococcus  faecalis.  Standard 
culture  revealed  a  biofilm  species 
composition in patient 2 of Staphy-
lococcus aureus (MRSA-negative) 
and Enterobacter cloacae.
The demonstration of living bac-
teria on tissue from an ulcer base 
suggests  that  a  well-developed 
mature biofilm can adhere to soft 
tissue.  In  orthopedic  infections, 
biofilms  are  usually  discussed  in 
the context of growth on a foreign 
body  (Costerton  2005)  or  dead 
bone. Our data show that infected 
foot  ulcers  from  diabetic  patients 
may also act as a reservoir for path-
ogenic biofilms. It has been specu-
lated for several years that bacteria 
that colonize chronic wounds exist 
as  biofilm  communities  (Serralta 
et  al.  2001,  Percival  and  Bowler 
2004).  Chronic  wound  infections 
share two important characteristics 
with  other  biofilm  diseases:  per-
sistent infection that is not cleared 
by  the  host  immune  system  and 
resistance to antimicrobial therapy. 
However, there has been very little 
direct evidence of biofilm involve-
ment in chronic wound infections 
(Kirketerp-Moller et al. 2008). We 
have identified viable biofilms with 
CLSM-based  visualization  tech-
niques on debrided tissue from dia-
betic patients with an infected ulcer, Acta Orthopaedica 2011; 82 (3): 383–385  385
treatment  may  therefore  include  improvement  of  the  blood 
circulation  (arterial  revascularization).  However,  we  found 
that infected foot ulcers may involve biofilm infection and the 
role of biofilms in treating infected foot ulcers is not usually 
addressed. Bacteria within mature biofilms are highly resist-
ant to many traditional antimicrobial therapies (Davis et al. 
2006).  For  example,  antibiotic  resistance  in  biofilm  bacte-
ria of up to 1,000 times that of planktonic bacteria has been 
extensively documented in experiments in vitro (Stewart and 
Costerton 2001). Thus, both systemic and topical antibiotics 
alone are unable to eradicate biofilm infections. This suggests 
that if systemic antibiotics are used, they must be used together 
with topical antiseptic and anti-biofilm strategies. Currently, 
one of the most successful strategies for the management of 
biofilm infections is physical removal of the biofilm, such as 
frequent  debridement  of  diabetic  foot  ulcers. This  includes 
proper wound cleansing and scraping off of all dead tissue. In 
addition, future treatment plans should consider application of 
local antibiotic-delivery systems, as in infected joint replace-
ments. With small cement beads or collagen fleeces, antibiotic 
concentrations at the site of infection can be achieved that are 
far higher than can be obtained after systemic application of 
the same antibiotic (Walenkamp 2001). As Pollard (2008) indi-
cated in a commentary recently, biofilm-based wound care is 
“a significant shift in our whole approach to wound healing”.
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